Goldman Sachs: Revolutionizing West Street Life Sciences with $650M
TLDR: Goldman Sachs Asset Management has raised $650 million for its West Street Life Sciences I fund. The fund is the first in the firm’s Life Sciences Investing strategy. Goldman Sachs Asset